Trulla
  • Home
  • Software
  • Services
    • Pharmacy Supply Chain Optimization
    • Planning a Distribution Center
    • Already Have a Distribution Center
  • Contact
  • About
  • Articles

Pharmacy CSC Webinar

12/17/2020

0 Comments

 
Are you considering a pharmacy CSC (consolidated services center) for your health system?  This recorded webinar dives into what you need to know when considering a pharmacy CSC.  Learn what services you should consider, challenges o watch out for, 340B complexities, licensure, and more! 

This webinar is presented by Angela Whitney, RPh and Curtis McEntire, who have been integral in the planning and operations of multiple pharmacy CSC's around the country.​

Click here to access the webinar.
Picture
0 Comments

System-Wide Medication Formulary Management

6/22/2020

0 Comments

 
Picture
Formulary management.  There are few words found within the pharmaceutical lexicon that elicit as much joy and exuberance as “formulary management”.  If you think that’s even remotely true, you must be new to formulary management.  With the (thankfully) increasing opinion that a health system should operate more like an actual system, the dire need for proper and auditable formulary management is becoming increasingly evident.  We can’t run a diverse health system with a one-size fits all approach and we also can’t efficiently serve our patients if we persist in the historical “every facility an island” approach.  Across the industry, we just don’t see good auditing tools to ensure that we’re purchasing the correct, optimized pharmaceuticals.  We’ve spoken previously about the unsung hero, the pharmacy buyer, and we can really give them and their clinic counterparts a leg up by handing them a tool that ensures proper formulary management and compliance.

There are lots of reasons why system-wide formulary management is complicated: hospital vs. clinic, patient populations, the 340B Drug Pricing Program, different regional needs, supplier access, and so on.  The list of why there hasn’t been a good solution to this is much shorter: no one that truly understands the industry has built a comprehensive tool for the industry, until now.  Trulla enables users to operate from the broadest sense (all active medications for an entire health system) to the absolute most narrow sense (the 15 medications that a seasonal shack on the backside of a mountain might need access to).
​
The way that Trulla approaches formulary management is novel in a few ways, not the least of which is that we recognize and respect that there are medications that a health system may need that they don’t want everyone purchasing at will and that the pharmacy buyer can never be replaced; they need the freedom to be able to purchase beyond machine-driven logic.  Trulla operates as a funnel to present a buyer with the optimized product, specific to their department and health system, but we don’t lock them into that product.  At the widest point of the funnel, we have access to all active medications with the FDA so that those managing the formulary don’t have to build each medication profile from scratch.  The next step in the narrowing funnel includes on formulary and off formulary medications, restricted medications, and so on.  As we narrow the funnel even more, Trulla allows for the restriction of a visible sub-formulary as it pertains to each buyer and their location. 

Let’s say there’s a system-level decision made by the P&T Committee, or the 340B team has new information about where to purchase X medication from to realize the best compliant price, Trulla allows for the operationalizing of that information.  A 340B clean site will see only those medications that they should have rights to purchase.  A non-340B clinic may see a broader sub-formulary but still doesn’t have access to everything an inpatient pharmacy would have access to, and so on.  Proper formulary management, coupled with a tool to operationalize it, creates an environment where even the administrative assistant at a clinic who’s thrown into a one time only purchasing situation can see the same results as the most experienced hospital buyer. 
​
Your goal is to save time and money while keeping patient safety at the forefront of every decision.  Formulary management may not be the first thing that comes to mind when thinking about saving time and money, but let Trulla show you a new angle that’s afforded by our software.  With the Trulla software you’ll have access to a ready-to-go, customizable medication list to begin building a broad formulary that serves as a source for any number of sub-formularies for those who purchase pharmaceuticals.  With our tools, you’ll have a united front all the way across your facility or health system, working together towards the same goals.
0 Comments

​Centralized Services Centers: GPO Prohibition

4/6/2018

0 Comments

 
Centralized Services Centers have been implemented or are being considered by numerous health systems to improve efficiency, reduce medication errors, and for the potential cost savings that can be captured. However, inventory management is extremely challenging when the Centralized Services Center (CSC) provides medications to both non-covered and covered entities (CEs). Ensure that the inventory management model selected does not expose the CEs to a GPO prohibition violation if they are required to comply with this requirement.

For example, some health systems have centralized the sterile compounding of products such as TPN and various antibiotics. If any of these products are administered to covered outpatients and purchased on GPO by the CSC, the CE could be at risk for a GPO prohibition violation unless a strategy is in place to prevent this from happening. The 2013 HRSA 340B Drug Pricing Program Notice Release No. 2013-1, Statutory Prohibition on Group Purchasing Organization Participation states, “Organizations that are not part of the 340B covered entity are not subject to the GPO prohibition; however, the 340B covered entity is still prohibited from having organizations purchase covered outpatient drugs through a GPO on its behalf or otherwise receive covered outpatient drugs purchased through a GPO.”

​One of several strategies to consider is to place these compounded products on a non-covered outpatient drug list. With this approach, they can be excluded from the 340B program and will not be subject to the GPO prohibition. The downside to this approach is that the individual ingredients cannot be purchased on 340B which could result in lost savings. If your health systems needs help determining a compliant approach, you can find a team of experts at Trulla (www.trullarx.com) or reach out to them directly by emailing  contact@trullarx.com.
0 Comments

    ARCHIVES

    November 2020
    September 2020
    August 2020
    June 2020
    May 2020
    March 2020
    June 2018
    April 2018
    February 2018

    Categories

    All
    340B
    Analytics
    Compounding
    Consolidate Service Centers
    Controlled Substances
    LUM Distribution
    Pharmacy
    Procurement
    Purchasing
    Shortage Management

    RSS Feed

    Disclaimer: The information provided in this article does not constitute legal advice and should not be construed as such. Readers of this document are encouraged to contact their attorney to obtain advice with respect to any particular legal matter. The views expressed in this document are those of the author and not those of the Trulla LLC. All liability with respect to actions taken or not taken based on the contents of this document are hereby expressly disclaimed. The content in this document is provided “as is;” no representations are made that the content is error-free.

Contact us to help you optimize your pharmacy procurement.

CONTACT US
Phone: (385) 258-3688
E-mail: contact@trullarx.com

  • Home
  • Software
  • Services
    • Pharmacy Supply Chain Optimization
    • Planning a Distribution Center
    • Already Have a Distribution Center
  • Contact
  • About
  • Articles